Eculizumab February 8, 2015[email protected] Eculizumab Trade Name Orphan Indication Dermatomyositis USA Market Approval USA USA Designation Date 2000-09-21 00:00:00 Sponsor Alexion Pharmaceuticals, Inc.;352 Knotter Drive;Cheshire, Connecticut, 06410
